AnaptysBio, Inc.(ANAB)
Biotech company with a royalty stream from a deal with GSK.
1 Insight
Investment Insights
AI-generated insights about AnaptysBio, Inc. from various financial sources
Monday, October 6, 2025
Very Bullish
Considered 'very, very exciting' and added to the speaker's long list due to its royalty stream, despite a noted history of wasting money.
Monday, October 6, 2025
Very Bullish
Considered 'very, very exciting' and added to the speaker's long list due to its royalty stream, despite a noted history of wasting money.